10.3748/wjg.v24.i48.5462 30 DuplancicB.StambolijaV.HoljevacJ.ZembaM.BalenovicI.DrmicD.et al (2014)
GIP is another gut hormone involved in insulin secretion and fat metabolism
Given the above and current knowledge, a clinically significant DDI between GLP1RAs and COCs is probably not expected, and there is no recommendation in any GLP1RA prescription sheet for dose adjustment of COCs in this context
Its essential to keep in mind that not all insurance plans cover semaglutide treatment, especially if its prescribed for weight loss rather than diabetes
And when you take it together with Wegovy, your risk may become more noticeable
Doses were inconsistent, side effects showed up more often than expected, and in some cases, the risks were serious enough to outweigh any potential benefits